ABEO — Abeona Therapeutics Inc
On NASDAQ, Abeona Therapeutics Inc trades as ABEO.
ABEO belongs to the HEALTHCARE sector and the BIOTECHNOLOGY industry.
To answer "what is ABEO worth" or "what is happening with Abeona Therapeutics Inc", VAQO shows a live price alongside technical analysis, relevant headlines and what other investors think.
VAQO's learning model reads seven technical indicators — short and long momentum, RSI, volatility, volume ratio, moving-average cross and position in the 52-week range — and turns them into transparent opportunity and risk scores.
What ABEO is
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for rare, life-threatening genetic diseases. The company is headquartered in New York, New York.…
Abeona Therapeutics Inc is classified under HEALTHCARE, in the BIOTECHNOLOGY industry.
It trades on NASDAQ as a common stock.
ABEO size and valuation
At roughly $286.5M, ABEO is a micro-cap.
Earnings per share are negative at -1.18, so there is no meaningful price-to-earnings multiple to quote.
Beta is 1.30: historically it has moved more than the market.
ABEO over the past year
Over the past year ABEO has traded between $4.00 and $7.65, and the current price sits at 5% of that range.
Trading near the low end of a 52-week range is a different situation from a bad day: it means the year, not the session, has gone against it.
The 50-day average is $5.96 against a 200-day average of $5.55 — the shorter average sits above the longer one, the configuration usually read as an uptrend.
The published analyst target is $18.88, 352.8% above it. A target is an aggregate of opinions, not a measurement.
How Abeona Therapeutics Inc (ABEO) is trading
Abeona Therapeutics Inc (ABEO) is up 6.65% at $4.17. A move that large in a single session sits well outside the normal daily range for most stocks.
The session ranged from $3.95 to $4.26 — 7.4% of the share price — and the current price sits at 71% of that range.
It opened at 0% of the daily range and finished at 71% of it: ABEO turned around inside the session, in the buyers' favour.
The day's range extended past the previous close ($3.91) on both sides.
Volume ran near 1.0M shares, about $4.4M of stock changing hands.
Traded alongside ABEO
Names traded alongside ABEO in the same sector: A (Agilent Technologies Inc), AAPG (Ascentage Pharma Group International), AARD (Aardvark Therapeutics Inc), ABCL (AbCellera Biologics Inc), ABOS (Acumen Pharmaceuticals Inc).
What VAQO's model says about ABEO
Two statistical models run over ABEO inside the browser, reporting momentum, risk and opportunity separately. Full accuracy for both, including when it falls, is published on the model page.
ABEO at a glance
- Symbol: ABEO
- Name: Abeona Therapeutics Inc
- Sector: HEALTHCARE
- Industry: BIOTECHNOLOGY
- Exchange: NASDAQ
- Instrument: Stock
ABEO — frequently asked questions
What is the market cap of ABEO?
Abeona Therapeutics Inc has a market capitalisation of roughly $286.5M.
What is the 52-week range for ABEO?
ABEO has traded between $4.00 and $7.65 over the past year, with the current price at 5% of that range.
How much does ABEO stock cost today?
Abeona Therapeutics Inc (ABEO) trades at $4.17, a change of +6.65% in the latest session.
Is ABEO up or down today?
ABEO is up 6.65% in the latest session, at $4.17.
What is the daily trading range for ABEO?
ABEO traded between $3.95 and $4.26 in the latest session, and currently trades at $4.17.
What is the trading volume for ABEO?
ABEO traded roughly 1.0M shares in the latest session.
Which exchange is ABEO listed on?
ABEO is listed on NASDAQ, in the HEALTHCARE sector.
Should I buy ABEO stock?
VAQO gives no buy or sell recommendations and is not an investment adviser. The ABEO figures on this page — price, range, volume and the model's scores — are there to inform your decision, not to stand in for it.
Traded alongside ABEO
- A — Agilent Technologies Inc
- AAPG — Ascentage Pharma Group International
- AARD — Aardvark Therapeutics Inc
- ABCL — AbCellera Biologics Inc
- ABOS — Acumen Pharmaceuticals Inc
- ABSI — Absci Corp
Last updated: 2026-11-08